DongKook Pharmaceutical Co., Ltd.
Financials
Valuation Metrics
DongKook Pharmaceutical Co., Ltd.'s Market Cap is ₩8246B. At end of 2025 it was ₩7757B. Ranked #324 of 2,436 in KR market (top 13%), #91 of 1,649 on KOSDAQ (top 6%), #37 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 16%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 824.55B KRW | KR#324/2,436 Sec#37/234 |
| Revenue | 954.16B KRW | KR#414/2,436 Sec#15/234 |
| Net Income | 82.27B KRW | KR#258/2,436 Sec#16/234 |
| Total Assets | 1.09T KRW | KR#444/2,436 Sec#24/234 |
| Net Assets | 780.60B KRW | KR#343/2,436 Sec#23/234 |
| Employees | 1,216 | KR#210/2,436 Sec#13/234 |
| Value | ||
| P/E | 10.02x | KR#712/2,436 Sec#37/234 |
| P/B | 1.06x | KR#1,531/2,436 Sec#100/234 |
| PEG | 0.22x | KR#544/2,436 Sec#30/234 |
| P/S | 0.86x | KR#1,286/2,436 Sec#70/234 |
| EV/EBITDA | 8.46x | KR#498/2,436 Sec#22/234 |
| FCF Yield | 3.16% | KR#990/2,436 Sec#64/234 |
| Profitability | ||
| ROE | 10.54% | KR#467/2,436 Sec#30/234 |
| ROA | 7.54% | KR#376/2,436 Sec#29/234 |
| Op. Margin | 10.33% | KR#474/2,436 Sec#45/234 |
| Revenue Growth | 12.19% | KR#842/2,436 Sec#73/234 |
| Earnings Growth | 46.43% | KR#590/2,436 Sec#35/234 |
| Financial Health | ||
| Debt Ratio | 39.81% | KR#140/2,436 Sec#17/234 |
| Total Debt | 67.98B KRW | KR#862/2,436 Sec#61/234 |
| FCF | 26.05B KRW | KR#446/2,436 Sec#26/234 |
| Cash | 58.69B KRW | KR#672/2,436 Sec#35/234 |
| Current Ratio | 2.06x | KR#913/2,436 Sec#106/234 |
| Net Debt/EBITDA | 0.09x | KR#698/2,436 Sec#44/234 |
| Dividend | ||
| Div. Yield | 1.14% | KR#1,104/2,436 Sec#64/234 |
| Div. Growth | 0.00% | KR—/2,436 Sec—/234 |
| Performance | ||
| 1Y Return | 1.56% | KR#681/2,436 Sec#51/234 |
| 1M Return | -9.30% | KR#1,718/2,436 Sec#172/234 |
| From 52W High | -41.66% | KR#837/2,436 Sec#60/234 |
| 1Y MDD | -44.68% | KR#691/2,436 Sec#53/234 |
| Trading | ||
| Volume | 200,366 shares | KR#572/2,436 Sec#55/234 |
| Foreign Own. | 14.51% | KR#327/2,436 Sec#22/234 |
| Per Share | ||
| EPS | 1,648 KRW | KR#448/2,436 Sec#30/234 |
| BPS | 15,058 KRW | KR#654/2,436 Sec#43/234 |
Company Info
Dongguk Pharmaceutical, established in 1968 and listed on KOSDAQ in 2007, is a pharmaceutical company with subsidiaries including Dongguk Pharmaceutical Life Science. It manufactures and sells over-the-counter drugs, prescription drugs, and active pharmaceutical ingredients, alongside supplying cosmetics, health functional foods, and household goods domestically and internationally. The company has built a strong production base through mass production of natural material ingredients, automated warehouses, and secure manufacturing spaces. It is expanding into a global pharmaceutical company by exporting new platform technology products overseas. The company is headquartered in Gangnam-gu, Seoul.